DynaMed vs Micromedex (2026)
Two reference incumbents that most hospitals encounter as a bundle rather than as a choice, since one vendor's combined product carries the other's drug content. DynaMed is the disease and condition reference, with a bounded generative layer over its own curated sets, output labelled as generative and an Epic marketplace listing that was actually reviewed. Micromedex is the drug and toxicology corpus and holds something no competitor does: recognition as a compendium under United States federal law, which gives its content standing in coverage decisions rather than only clinical ones. If you are choosing what to ground an AI product in, that compendium status is the strongest single fact in this category. Neither publishes a security attestation, which for products at this deployment scale remains the more surprising finding.
- The corpus is bounded to the vendor's own curated content sets with a retrieval framework named, generative output labelled as generative, and a published principle limiting generative use in user facing applications.
- An Epic marketplace listing from 2021 is a reviewed integration credential rather than a partnership claim, alongside institutional single sign on.
- Disease and condition reference is the primary job, with separate products for nursing and pharmacy readers rather than one corpus stretched across all three.
- It holds a regulatory standing nothing else in this category has, recognised as a drug compendium under United States federal law, which reaches coverage and reimbursement decisions.
- Depth in drug information, interactions, intravenous administration and toxicology, in use across more than eighty countries including poison control centres.
- A peer reviewed usability evaluation exists with authors from a major academic hospital, which is more external assessment than most reference products carry.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. DynaMed and Micromedex are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | DynaMed | Micromedex |
|---|---|---|
| Primary category | Clinical Reference & Evidence | Clinical Reference & Evidence |
| Headquarters | Ipswich, Massachusetts | Ann Arbor, Michigan |
| Website | dynamed.com | merative.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards DynaMed its top capability grade on EHR and Interoperability Depth. Set against Micromedex, DynaMed grades higher on several axes, including Model and Technology Transparency, AI Safety and PHI Stewardship and AI Governance and Bias Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index records no top capability grade for Micromedex on any axis it scores. Set against DynaMed, Micromedex grades higher on FDA and Regulatory Status. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose DynaMed or Micromedex?
On the axes where the AI Health Index separates them, DynaMed grades higher on several axes, including Model and Technology Transparency, AI Safety and PHI Stewardship and AI Governance and Bias Disclosure, and Micromedex grades higher on FDA and Regulatory Status. DynaMed leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do DynaMed and Micromedex differ most?
The widest separation the AI Health Index records between DynaMed and Micromedex is on Model and Technology Transparency, where DynaMed grades B and Micromedex grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do DynaMed and Micromedex grade the same?
The AI Health Index grades DynaMed and Micromedex the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model Supply Chain Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
These are frequently bought together rather than against each other, and one vendor's combined product bundles the other's drug content, so establish what you already have before treating this as a choice. Neither publishes a security attestation, trust centre, penetration testing statement or vulnerability disclosure programme across repeated passes, which is a conspicuous gap for products deployed across thousands of hospitals. Neither publishes a bias evaluation or an error taxonomy for its generative layer, and neither publishes a mechanism for detecting a superseded entry, which is the failure mode of any curated corpus.